Literature DB >> 21430749

Cancer: Missing the mark.

Lizzie Buchen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21430749     DOI： 10.1038/471428a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection.

Authors:  B Schweitzer; S Wiltshire; J Lambert; S O'Malley; K Kukanskis; Z Zhu; S F Kingsmore; P M Lizardi; D C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  Diagnostic markers for early detection of ovarian cancer.

Authors:  Irene Visintin; Ziding Feng; Gary Longton; David C Ward; Ayesha B Alvero; Yinglei Lai; Jeannette Tenthorey; Aliza Leiser; Ruben Flores-Saaib; Herbert Yu; Masoud Azori; Thomas Rutherford; Peter E Schwartz; Gil Mor
Journal:  Clin Cancer Res       Date:  2008-02-07       Impact factor: 12.531

3.  Ovarian cancer early detection claims are biased.

Authors:  Martin McIntosh; Garnet Anderson; Charles Drescher; Samir Hanash; Nicole Urban; Pat Brown; Sanjiv Sam Gambhir; George Coukos; Peter W Laird; Brad Nelson; Chana Palmer
Journal:  Clin Cancer Res       Date:  2008-10-23       Impact factor: 12.531

4.  The importance of test positive predictive value in ovarian cancer screening.

Authors:  Mark H Greene; Ziding Feng; Mitchell H Gail
Journal:  Clin Cancer Res       Date:  2008-10-23       Impact factor: 12.531

5.  A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.

Authors:  Claire S Zhu; Paul F Pinsky; Daniel W Cramer; David F Ransohoff; Patricia Hartge; Ruth M Pfeiffer; Nicole Urban; Gil Mor; Robert C Bast; Lee E Moore; Anna E Lokshin; Martin W McIntosh; Steven J Skates; Allison Vitonis; Zhen Zhang; David C Ward; James T Symanowski; Aleksey Lomakin; Eric T Fung; Patrick M Sluss; Nathalie Scholler; Karen H Lu; Adele M Marrangoni; Christos Patriotis; Sudhir Srivastava; Saundra S Buys; Christine D Berg
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

6.  Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

Authors:  Daniel W Cramer; Robert C Bast; Christine D Berg; Eleftherios P Diamandis; Andrew K Godwin; Patricia Hartge; Anna E Lokshin; Karen H Lu; Martin W McIntosh; Gil Mor; Christos Patriotis; Paul F Pinsky; Mark D Thornquist; Nathalie Scholler; Steven J Skates; Patrick M Sluss; Sudhir Srivastava; David C Ward; Zhen Zhang; Claire S Zhu; Nicole Urban
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

7.  Challenges related to developing serum-based biomarkers for early ovarian cancer detection.

Authors:  Phuong L Mai; Nicolas Wentzensen; Mark H Greene
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

8.  Serum protein markers for early detection of ovarian cancer.

Authors:  Gil Mor; Irene Visintin; Yinglei Lai; Hongyu Zhao; Peter Schwartz; Thomas Rutherford; Luo Yue; Patricia Bray-Ward; David C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-12       Impact factor: 11.205

9.  Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

10.  Effects of blood collection conditions on ovarian cancer serum markers.

Authors:  Jason D Thorpe; Xiaobo Duan; Robin Forrest; Kimberly Lowe; Lauren Brown; Elliot Segal; Brad Nelson; Garnet L Anderson; Martin McIntosh; Nicole Urban
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240
View more
  21 in total

1.  Precision medicine and the FDA's draft guidance on laboratory-developed tests.

Authors:  Thomas J Hwang; Lisa Soleymani Lehmann; Aaron S Kesselheim
Journal:  Nat Biotechnol       Date:  2015-05       Impact factor: 54.908

2.  Identifying early events of gene expression in breast cancer with systems biology phylogenetics.

Authors:  M S Abu-Asab; N Abu-Asab; C A Loffredo; R Clarke; H Amri
Journal:  Cytogenet Genome Res       Date:  2013-04-03       Impact factor: 1.636

3.  Application of proteomics to cancer early detection.

Authors:  Samir Hanash; Ayumu Taguchi
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

4.  Early developments in gene-expression profiling of breast tumors: potential for increasing black-white patient disparities in breast cancer outcomes?

Authors:  Donna H Odierna; Aimee Afable-Munsuz; Ogechi Ikediobi; Mary Beattie; Sara Knight; Michelle Ko; Adrienne Wilson; Ninez A Ponce
Journal:  Per Med       Date:  2011-11       Impact factor: 2.512

5.  Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model.

Authors:  Subbulakshmi Karthikeyan; Angela Russo; Matthew Dean; Daniel D Lantvit; Michael Endsley; Joanna E Burdette
Journal:  Cancer Lett       Date:  2018-07-05       Impact factor: 8.679

Review 6.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Richard Macey; Tanya Walsh; Paul Brocklehurst; Alexander R Kerr; Joseph L Y Liu; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

7.  Discovery of primary prostate cancer biomarkers using cross cancer learning.

Authors:  Kaiyue Zhou; Suzan Arslanturk; Douglas B Craig; Elisabeth Heath; Sorin Draghici
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

Review 8.  Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

Authors:  Tanya Walsh; Joseph L Y Liu; Paul Brocklehurst; Anne-Marie Glenny; Mark Lingen; Alexander R Kerr; Graham Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2013-11-21

9.  The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?

Authors:  Eleftherios P Diamandis
Journal:  BMC Med       Date:  2012-08-09       Impact factor: 8.775

Review 10.  Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome.

Authors:  Ferdinando Mannello; Daniela Ligi
Journal:  BMC Cancer       Date:  2013-07-12       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.